Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children’s Oncology Group
暂无分享,去创建一个
W. Woods | J. Neglia | Zhengjia Chen | G. Reaman | P. Gaynon | R. Wells | M. Krailo | N. Seibel | Julie R. Park | H. Meany | D. Villaluna | J. Sato | R. Hutchinson